VJHemOnc is committed to improving our service to you

VJVirtual | GvHD & GvL in secondary AML

VJHemOnc is committed to improving our service to you

Arnon Nagler

Arnon Nagler, MD, MSc, Sheba Medical Center, Tel-Aviv, Israel, discusses graft-versus-host disease (GvHD) and graft-versus-leukemia (GvL) effects in secondary acute myeloid leukemia (AML) treated with transplantation. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter